SINCE anticoagulant therapy of occlusive vascular diseases of the retina is rapidly assuming an important place in the armamentarium of the ophthalmologist, it is important that we review the efficiency, as well as the dangers and contraindications, of this form of treatment. It is the purpose of this paper to analyze the results of bishydroxycoumarin U. S. P. (dicumarol®) and heparin therapy in the management of occlusive vascular disease of the retina at the University Hospital during the past few years. We have attempted to establish a control for the present study by reviewing the end-results in all untreated patients seen here since 1935.
The accumulated experience of the world literature1 with anticoagulant drugs in treatment of thrombosis of the retinal veins has been summarized in Tables 1, 2, and 3. Since patients with secondary glaucoma were excluded from treatment, the material is admittedly selective. Of 109 patients with
DUFF IF, FALLS HF, LINMAN JW. ANTICOAGULANT THERAPY IN OCCLUSIVE VASCULAR DISEASE OF THE RETINA. AMA Arch Ophthalmol. 1951;46(6):601-617. doi:10.1001/archopht.1951.01700020615001